Complex generics will boost speciality biz, Teva says
Complex generics will boost speciality biz, Teva says By Dan Stanton+, 16-Jan-2014 Complex generics will represent over 50% of Teva’s generic market by 2017, the firm says, but investments in delivery technology will have positive implications across the full business. http://www.in-pharmatechnologist.com/Drug-Delivery/Complex-generics-will-boost-speciality-biz-Teva-says